Kosmos Energy Ltd. Common Shares (DE) vs Eli Lilly And Co — how do they compare? Kosmos Energy Ltd. Common Shares (DE) trades at $2.71 (market cap $1.66B), while Eli Lilly And Co trades at $1,221 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 626.5× Kosmos Energy Ltd. Common Shares (DE)'s market cap, and Eli Lilly And Co pays a 0.59% dividend while Kosmos Energy Ltd. Common Shares (DE) pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kosmos Energy Ltd. Common Shares (DE) for 0 Days and Eli Lilly And Co for 94 Days on average.
| KOS | LLY | |
|---|---|---|
Market Cap | $1.66B | $1.04T |
Volume | 7,535,344 | 1,843,375 |
Sector | Energy | Health |
52-Week High | $3.27 | $1.28K |
52-Week Low | $0.87 | $799.57 |
Typical Hold Time | 0 Days | 94 Days |
Enterprise Value | $4.30B | $1.09T |
Dividend Yield | — | 0.59% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,211.40, up 2.43% today, with a bullish technical outlook and strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $8.38 surpassing the $6.40 estimate. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Positive news flow highlights pipeline advancements in weight-loss drugs, including EloraTZP's promising trial results.
Outlook remains positive given dominant market position in obesity and diabetes treatments, with analyst consensus price target of $1,350 implying ~11% upside. Key risks include competitive pressures from Novo Nordisk and regulatory hurdles. Earnings growth and pipeline catalysts support further appreciation, though high valuations warrant monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Kosmos Energy Ltd. is a deepwater oil and gas exploration and production company with operations offshore Ghana, Equatorial Guinea, Mauritania, and Senegal in West Africa.
Read more on KOS →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →